You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Answer a few questions to help determine whether a specialised consultation could help your patient.
Assess Spasticity is a questionnaire consisting of ten questions that may help identify potential candidates for a screening test or whether patients would benefit from a specialised consultation where spasticity can be further evaluated. Recommendations are based on best practices1 and expert guidance2,3. Although the recommendations are the result of a careful and scientifically validated approach, they still reflect recommendations and should not be interpreted as a 'gold standard' for any given patient. The programme should be viewed as a 'professional mirror' to compare your own decisions with the best practices and expert guidance. The programme is meant to assist you in forming your medical judgment but should not interfere with your independent diagnosis and treatment decision. The indicated programme recommendation for a given patient should not preclude a final decision to be made by you or a competent medical team in a specialised centre for spasticity therapy, as to whether the therapy should be recommended or not.
The use of Intrathecal Drug Delivery for spasticity is not for everyone. Not everyone will receive the same results.
Saulino M., Ivanhoe C.B., McGuire J.R., Ridley B., Shilt J.S., Boster A.L. Neuromodulation 2016 Aug;19(6):607-15.
Lanig IS, New PW, Burns AS, Optimizing the Management of Spasticity in People With Spinal Cord Damage: A Clinical Care Pathway for Assessment and Treatment Decision Making From the Ability Network, an International Initiative. Arch Phys Med Rehabil. 2018 Aug;99(8):1681-1687
Ivanhoe CB, Tilton AH, Francisco GE. Phys Med Rehabil Clin N Am. 2001 Nov; 12(4); 923-38, viii-ix.
Refer to the drug manufacturer's package insert for a complete list of indication, contraindication, warning, precautions, adverse events and dosage and administration information.
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu.
For applicable products consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.